Pharmalot Tags pharmaceuticalsrecruitingSTAT+ About the Author Reprints What is it? By Ed Silverman June 16, 2017 Reprints Ed Silverman Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Up and down the ladder: The latest comings and goings Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot?Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. What’s included? Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. GET STARTED Log In | Learn More @Pharmalot Alex Hogan/STAT [email protected] Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.